China Shenghuo Pharmaceutical Holdings, Inc. KUN Securities Stock Fraud

- by

Company: China Shenghuo Pharmaceutical Holdings, Inc.
Ticker Symbol: KUN
Class Period: Jul-23-07 to Aug-20-08
Date Filed: Aug-23-08
Lead Plaintiff Deadline: Oct-22-08
Court: Southern District of New York
A class action lawsuit on behalf of all purchasers of China Shenghuo Pharmaceutical Holdings, Inc. common stock during the period from July 23, 2007 through and including August 20, 2008 (the "Class Period").

No class has yet been certified in the above action.

The complaint charges that CSP and certain of its officers and directors violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by issuing materially false and misleading statements pertaining to CSP's business prospects and condition, and filing materially false financial statements with the SEC. On August 20, 2008, the Company announced that its previously issued financial statements for the fiscal periods ended June 30, September 30, and December 30, 2007 and fiscal quarter ended March 31, 2008, should no longer be relied upon and would be restated due to certain accounting errors, internal control issues and related matters. News that the Company's financial statements must be restated caused the Company's stock price to fall dramatically damaging investors.

If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

China Shenghuo Pharmaceutical Holdings, Inc. KUN Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible China Shenghuo Pharmaceutical Holdings, Inc. securities class action lawsuit. Please fill in our form on the right to submit your complaint for a free evaluation.

Maybe it's your stockbroker

Add Your Comment on This Issue

Please read our comment guidelines before posting.

Note: Your name will be published with your comment.

Your email will only be used if a response is needed.

Request Legal Help